Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01640522 · ClinicalTrials.gov registry record · NA
Comprehensive Electronic Cancer Support System for the Treatment of Cancer Related Symptoms
A NA study of Pancreatic Cancer and Hepatocellular Carcinoma, sponsored by University of Pittsburgh.
- Completed
- Registry status
- NA
- Development phase
- 261
- Enrollment target
- 1
- Study location
NCT01640522 is a NA study of Pancreatic Cancer and Hepatocellular Carcinoma that has completed, run by University of Pittsburgh. The registered enrollment target is 261 participants, below the 392-participant average among 278 other Pancreatic Cancer trials with a reported enrollment target (33% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01640522, a NA study of Pancreatic Cancer and Hepatocellular Carcinoma, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- NA
- Development phase
- 261 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to test the efficacy of a collaborative care intervention to manage cancer-related symptoms and improve health related quality of life in patients diagnosed with hepatobiliary carcinoma.
Conditions Studied
Interventions
- OTHER Collaborative Care
- OTHER Enhanced usual Care
Study Locations (1)
Pennsylvania
- University of Pittsburgh Medical Center - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 261 participants |
| Start Date | 2008-01 |
| Est. Completion | 2014-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01640522
The ClinicalTrials.gov registry entry for NCT01640522 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 261 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 392-participant average among 278 other Pancreatic Cancer trials with a reported enrollment target (33% lower). The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 7 conditions, with Pancreatic Cancer appearing as the primary indexed condition, and to 2 interventions - of which Collaborative Care is the first listed.
NCT01640522 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT01640522 about?
NCT01640522 is a clinical study titled "Comprehensive Electronic Cancer Support System for the Treatment of Cancer Related Symptoms". The purpose of this study is to test the efficacy of a collaborative care intervention to manage cancer-related symptoms and improve health related quality of life in patients diagnosed with hepatobiliary carcinoma.
What is the current status of trial NCT01640522?
This trial is currently completed. It is a NA study. The enrollment target is 261 participants. The study started on 2008-01. Estimated completion is 2014-12.
What conditions does trial NCT01640522 study?
This clinical trial studies the following conditions: Pancreatic Cancer, Hepatocellular Carcinoma, Colorectal Carcinoma, Liver Metastases, Bile Duct Cancer.
What interventions are being tested in trial NCT01640522?
The interventions under investigation include: Collaborative Care (OTHER), Enhanced usual Care (OTHER).
Who is sponsoring clinical trial NCT01640522?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01640522 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pancreatic Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Alpha Radiation Emitters Device for the Treatment of Pancreatic Cancer With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic Cancer
RECRUITING · NA
-
A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
RECRUITING · NA
-
EUS Examination Using EndoSound Vision System vs. Standard Echoendoscope
RECRUITING · NA
-
Computed Tomography in Diagnosing Patients With Pancreatic or Hepatobiliary Cancer
RECRUITING · NA
-
Support Through Remote Observation and Nutrition Guidance Program (STRONG-PCS)
RECRUITING · NA
-
GENOCARE: A Prospective, Randomized Clinical Trial of Genotype-Guided Dosing Versus Usual Care
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.